mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |